|
Harker, L A (1998) Therapeutic inhibition of thrombin activities, receptors, and production. Hematol Oncol Clin North Am 12:1211-30
|
|
Sundell, I B; Marzec, U M; Kelly, A B et al. (1997) Reduction in stent and vascular graft thrombosis and enhancement of thrombolysis by recombinant Lys-plasminogen in nonhuman primates. Circulation 96:941-8
|
|
Harker, L A; Hanson, S R; Kelly, A B (1997) Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation. Thromb Haemost 78:736-41
|
|
Dichek, D A; Anderson, J; Kelly, A B et al. (1996) Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 93:301-9
|
|
Runge, M S; Harker, L A; Bode, C et al. (1996) Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation 94:1412-22
|
|
Yokoyama, T; Kelly, A B; Marzec, U M et al. (1995) Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates. Circulation 92:485-91
|
|
Scott, N A; Robinson, K A; Nunes, G L et al. (1995) Comparison of the thrombogenicity of stainless steel and tantalum coronary stents. Am Heart J 129:866-72
|
|
Tomer, A; Scharf, R E; McMillan, R et al. (1994) Bernard-Soulier syndrome: quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements. Eur J Haematol 52:193-200
|
|
Cadroy, Y; Hanson, S R; Kelly, A B et al. (1994) Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood 83:3218-24
|
|
Cadroy, Y; Hanson, S R; Harker, L A (1993) Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates. Arterioscler Thromb 13:1213-7
|
Showing the most recent 10 out of 30 publications
